Free Newsletter
A closer look at industry issues
As we announced several weeks ago, FiercePharma will be featuring a new special section called Industry Voices. A variety of columnists will discuss issues affecting the pharmaceutical industry and examine the trends that are changing the way drug makers do business. We hope this feature will give you deeper insight into larger issues that don't always make the daily news cycle.
Our first columnist is Mark Senak, an industry expert with over twenty years of experience in law, communications, public health and public relations. He is also the author of Eye on FDA, a popular blog covering the ins and outs of FDA news and policy. Scroll down to check out his article on the recent upheaval at the FDA, or click here to read it online. - Maureen
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





